Amedeo Smart

Free Medical Literature Service

 

Amedeo

Valvular Heart Disease
  Free Subscription

Articles published in
Heart
    April 2026
  1. BRAVER J, Marwick TH, Nolan J, Petitjean C, et al
    Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study.
    Heart. 2026 Apr 3:heartjnl-2025-327186. doi: 10.1136/heartjnl-2025-327186.
    >> Share

  2. USEINI D, Kutschka I, Baraki H
    Correspondence on 'Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk', by Marin-Cuartas et al.
    Heart. 2026 Apr 3:heartjnl-2026-328122. doi: 10.1136/heartjnl-2026-328122.
    >> Share

    March 2026
  3. MASILAMANI MSJ, Raj V, Raj S
    Adolescent male with aortic valve mass.
    Heart. 2026;112:467-468.
    >> Share

  4. TREVIS J, Cheong J, Wilkinson C, Ogundimu E, et al
    Mechanical versus biological aortic valve replacement in patients aged 50-70 years: a systematic review and meta-analysis.
    Heart. 2026 Mar 18:heartjnl-2025-327763. doi: 10.1136/heartjnl-2025-327763.
    >> Share

  5. BUTCHER SC, Lewin S, Budgeon CA, Walker J, et al
    Life expectancy and determinants of relative survival following surgical aortic valve replacement for aortic stenosis.
    Heart. 2026 Mar 18:heartjnl-2025-327029. doi: 10.1136/heartjnl-2025-327029.
    >> Share

  6. YADAV S, Bansal D, V B, Kumar S, et al
    Rare cardiac outpouching in rheumatic mitral valve disease.
    Heart. 2026;112:409-410.
    >> Share

  7. BAAY M, Hosseini Z, Zadgari E, Moayerifar M, et al
    Impact of advanced cardiac damage in severe aortic stenosis on short-term and mid-term mortality and rehospitalisation after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Heart. 2026 Mar 6:heartjnl-2025-326941. doi: 10.1136/heartjnl-2025-326941.
    >> Share

    February 2026
  8. SCHOONVELDE SAC, Zwetsloot PP, Hirsch A, Schinkel AFL, et al
    Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy.
    Heart. 2026;112:333-340.
    >> Share

  9. LOKESH N, Kannarkat JT, Reardon MJ
    Assessing transcatheter tricuspid valve replacement: evidence, viability and adoption.
    Heart. 2026 Feb 16:heartjnl-2025-327129. doi: 10.1136/heartjnl-2025-327129.
    >> Share

  10. MARIN-CUARTAS M, Kawczynski MJ, de Waha S, Kiefer P, et al
    Updated 5-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk.
    Heart. 2026 Feb 11:heartjnl-2025-327092. doi: 10.1136/heartjnl-2025-327092.
    >> Share

    January 2026
  11. ADELI A, Swahn E, Lind L, Soderberg S, et al
    Sex differences in the prevalence and risk factors for aortic valve calcification in the general population.
    Heart. 2026 Jan 29:heartjnl-2025-326468. doi: 10.1136/heartjnl-2025-326468.
    >> Share

  12. HEITZINGER G, Torrefranca CS, Koschatko S, Jantsch C, et al
    Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study.
    Heart. 2026 Jan 21:heartjnl-2025-326808. doi: 10.1136/heartjnl-2025-326808.
    >> Share

  13. YOON J, Liabot Q, Jamieson C, MacLeod B, et al
    Transcatheter aortic valve degeneration: a combined clinical and translational perspective.
    Heart. 2026 Jan 19:heartjnl-2025-326405. doi: 10.1136/heartjnl-2025-326405.
    >> Share

  14. KASPRZAK JD
    Progression of valvular heart disease: an academic concept or a clinical imperative?
    Heart. 2026 Jan 12:heartjnl-2025-327550. doi: 10.1136/heartjnl-2025-327550.
    >> Share

    December 2025
  15. ZHOU Z, Zheng Y, Hu S, Xu J, et al
    Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian randomisation analysis.
    Heart. 2025 Dec 29:heartjnl-2025-326058. doi: 10.1136/heartjnl-2025-326058.
    >> Share

  16. DAVIDSEN AH, Andersen S, Halvorsen PA, Aviles Solis JC, et al
    Heart murmurs in the general population: diagnostic value and prevalence from the Tromso Study.
    Heart. 2025;112:103-110.
    >> Share

  17. CHEN M, Sahiti F, Cejka V, Schmidbauer L, et al
    Frequency and natural course of American College of Cardiology/American Heart Association valvular heart disease stages in the general population: results from the population-based STAAB cohort study.
    Heart. 2025 Dec 9:heartjnl-2025-326443. doi: 10.1136/heartjnl-2025-326443.
    >> Share

    November 2025
  18. CHEN M, Yue Z, Xu L, Fan P, et al
    Prosthetic annulus size mismatch and recurrent mitral regurgitation after repair in advanced degenerative disease.
    Heart. 2025 Nov 30:heartjnl-2025-325968. doi: 10.1136/heartjnl-2025-325968.
    >> Share

  19. MALAHFJI M
    Natural history of aortic regurgitation in the contemporary era: not so benign.
    Heart. 2025 Nov 24:heartjnl-2025-327335. doi: 10.1136/heartjnl-2025-327335.
    >> Share

  20. NASER JA, Massad F, Al-Abcha A, Gerberi D, et al
    Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis.
    Heart. 2025 Nov 17:heartjnl-2025-326643. doi: 10.1136/heartjnl-2025-326643.
    >> Share

  21. SALIHU A, Antiochos P, Lu H, Maurizi N, et al
    Association between programmed electrical stimulation inducibility and arrhythmic risk in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Heart. 2025;111:1135-1140.
    >> Share

  22. ABDALWAHAB A, Das R, Alkhalil M
    Inferior ST-segment elevation during transcatheter aortic valve implantation.
    Heart. 2025;111:1167-1168.
    >> Share

    October 2025
  23. VAN WIJNGAARDEN AL, de Riva M, Sabbag A, El-Am E, et al
    Ventricular arrhythmias during exercise in patients with mitral valve prolapse.
    Heart. 2025 Oct 20:heartjnl-2025-326395. doi: 10.1136/heartjnl-2025-326395.
    >> Share

  24. LOVE CJ, Lampert J, Huneycutt D, Musat DL, et al
    Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.
    Heart. 2025;111:1029-1035.
    >> Share

    September 2025
  25. WANG H, Li J, Hsi DH, Li W, et al
    Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy.
    Heart. 2025;111:933-940.
    >> Share

  26. NISHIURA N, Kubo S, Ono S, Mushiake K, et al
    Prognostic value of leaflet coaptation gap in transcatheter edge-to-edge repair for functional mitral regurgitation.
    Heart. 2025 Sep 8:heartjnl-2024-325585. doi: 10.1136/heartjnl-2024-325585.
    >> Share

  27. JIA S, Liu P, Wang M, Zhong X, et al
    Midterm outcomes of rheumatic mitral valve repair versus replacement in a dual-centre retrospective study.
    Heart. 2025 Sep 5:heartjnl-2025-326323. doi: 10.1136/heartjnl-2025-326323.
    >> Share

    August 2025
  28. KUBO T, Sugiura K, Tokita Y, Takano H, et al
    Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.
    Heart. 2025;111:885-892.
    >> Share

  29. WANG Z, Qian X, Lv J, Li Z, et al
    Asthma and risk of degenerative valvular heart disease: a prospective cohort study.
    Heart. 2025 Aug 19:heartjnl-2024-325575. doi: 10.1136/heartjnl-2024-325575.
    >> Share

  30. CAO D, Sandri M, Garot P, Pelliccia F, et al
    Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation.
    Heart. 2025 Aug 12:heartjnl-2025-326043. doi: 10.1136/heartjnl-2025-326043.
    >> Share

  31. TSURUMI H, Kusunose K
    Atrial fibrillation in chronic aortic regurgitation: the missing link in prognosis and surgical timing.
    Heart. 2025 Aug 11:heartjnl-2025-326727. doi: 10.1136/heartjnl-2025-326727.
    >> Share

  32. BARBOSA GS, Katsuyama ES, Fukunaga CK, Fernandes JM, et al
    Surgical ablation in non-mitral valve cardiac surgeries: a meta-analysis of early outcomes.
    Heart. 2025 Aug 7:heartjnl-2025-326299. doi: 10.1136/heartjnl-2025-326299.
    >> Share

  33. XIANG H, Zhang Y, Zhang Y, Ye Z, et al
    Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies.
    Heart. 2025 Aug 4:heartjnl-2025-326161. doi: 10.1136/heartjnl-2025-326161.
    >> Share

    July 2025
  34. BHARUCHA AH, Brown S, Theofilatos K, Singh B, et al
    Parsimonious machine learning model to predict 1-year mortality and procedural futility after transcatheter aortic valve replacement.
    Heart. 2025 Jul 25:heartjnl-2025-325928. doi: 10.1136/heartjnl-2025-325928.
    >> Share

  35. MATTIG I, Romero Dorta E, Frumkin D, Kretzschmar H, et al
    Sex differences in the prevalence and prognosis of tricuspid regurgitation among patients with heart failure.
    Heart. 2025 Jul 24:heartjnl-2025-325913. doi: 10.1136/heartjnl-2025-325913.
    >> Share

  36. CHANG CJ, Chi NH, Wu CH, Huang LY, et al
    Comparative evaluation of biological and mechanical prostheses for aortic valve replacement in a middle-aged population: a population-based cohort study.
    Heart. 2025 Jul 16:heartjnl-2024-325648. doi: 10.1136/heartjnl-2024-325648.
    >> Share

  37. PUGLIESI GM, Scott CG, Nkomo VT, Michelena HI, et al
    Prevalence and prognostic role of atrial fibrillation in chronic severe aortic regurgitation.
    Heart. 2025 Jul 16:heartjnl-2025-325823. doi: 10.1136/heartjnl-2025-325823.
    >> Share

  38. WILLIXHOFER R, Mapelli M, Baracchini N, Campana N, et al
    Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathy.
    Heart. 2025;111:700-705.
    >> Share

  39. TOMSIC A, Velders BJJ, Kawczynski MJ, Schoones JW, et al
    Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts.
    Heart. 2025 Jul 8:heartjnl-2025-326162. doi: 10.1136/heartjnl-2025-326162.
    >> Share

    June 2025
  40. LIM HJ, Kim K, Gwak SY, Lee HJ, et al
    Early predictors of aortic valve surgery in patients with significant bicuspid aortic regurgitation without initial surgical indication.
    Heart. 2025 Jun 20:heartjnl-2025-325892. doi: 10.1136/heartjnl-2025-325892.
    >> Share

  41. FALK V
    60: 'the magic number of greatness' in minimally invasive mitral valve repair?
    Heart. 2025 Jun 20:heartjnl-2025-326326. doi: 10.1136/heartjnl-2025-326326.
    >> Share

  42. KASSAR M, Gercek M, Rudolph V
    Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice.
    Heart. 2025 Jun 15:heartjnl-2024-325621. doi: 10.1136/heartjnl-2024-325621.
    >> Share

  43. HEUTS S, Kawczynski MJ, Maesen B, Vriesendorp PA, et al
    When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.
    Heart. 2025 Jun 10:heartjnl-2025-326208. doi: 10.1136/heartjnl-2025-326208.
    >> Share

    May 2025
  44. SUN Y, Wang C, Li J, Luo S, et al
    Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
    Heart. 2025 May 10:heartjnl-2024-324697. doi: 10.1136/heartjnl-2024-324697.
    >> Share

  45. NAKASE M, Draxler DF, Tomii D, Heg D, et al
    Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement.
    Heart. 2025 May 10:heartjnl-2024-325359. doi: 10.1136/heartjnl-2024-325359.
    >> Share

  46. HEUTS S, Hjij W, Kawczynski MJ, Olsthoorn JR, et al
    Defining centres of expertise for minimally invasive mitral valve surgery: a systematic review and volume-outcome meta-analysis.
    Heart. 2025 May 10:heartjnl-2024-325048. doi: 10.1136/heartjnl-2024-325048.
    >> Share

    April 2025
  47. WANG C, Hamid N, Bapat V, Cavalcante JL, et al
    Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
    Heart. 2025 Apr 30:heartjnl-2024-325194. doi: 10.1136/heartjnl-2024-325194.
    >> Share

  48. MCCANN GP, Newby DE, Hillis GS
    TAVI for asymptomatic aortic stenosis? More compelling outcome data are needed.
    Heart. 2025 Apr 15:heartjnl-2025-325767. doi: 10.1136/heartjnl-2025-325767.
    >> Share

  49. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    >> Share

    March 2025
  50. CELMETA B, Miceli A
    Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key.
    Heart. 2025 Mar 23:heartjnl-2024-325410. doi: 10.1136/heartjnl-2024-325410.
    >> Share

  51. GEERS J, Manral N, Razipour A, Park C, et al
    Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
    Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925.
    >> Share

  52. PANG L, Xia Y, Tang M, Ma M, et al
    Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
    Heart. 2025 Mar 3:heartjnl-2024-325221. doi: 10.1136/heartjnl-2024-325221.
    >> Share

    February 2025
  53. LEE HJ, Gwak SY, Kim K, Cho I, et al
    Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy.
    Heart. 2025;111:253-261.
    >> Share

  54. LIND V, Lundman P, Friberg L, Talback M, et al
    Dysglycaemia and incident aortic stenosis: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325150. doi: 10.1136/heartjnl-2024-325150.
    >> Share

  55. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    >> Share

  56. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    >> Share

  57. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    >> Share

    January 2025
  58. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    >> Share

  59. CRAIG N, Dweck MR
    Sociodemographic treatment trends for aortic stenosis since the adoption of transcatheter aortic valve intervention.
    Heart. 2025 Jan 16:heartjnl-2024-325328. doi: 10.1136/heartjnl-2024-325328.
    >> Share

  60. DONAL E, Gegout L, Bourg C
    Reassessing the role of tricuspid valve surgery in the modern era.
    Heart. 2025 Jan 16:heartjnl-2024-325476. doi: 10.1136/heartjnl-2024-325476.
    >> Share

    December 2024
  61. LIU R, Fu Z, Yan Y, Xie M, et al
    New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
    >> Share

  62. DOEDENS A, Skarp S, Holmstrom L, Pakanen L, et al
    Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
    Heart. 2024;111:55-61.
    >> Share

  63. PLAYFORD D, Stewart S, Harris SA, Scalia G, et al
    Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography.
    Heart. 2024 Dec 20:heartjnl-2024-324790. doi: 10.1136/heartjnl-2024-324790.
    >> Share

  64. HADJI-TURDEGHAL K, Petersen JK, Graversen PL, Butt JH, et al
    Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
    Heart. 2024 Dec 20:heartjnl-2024-324803. doi: 10.1136/heartjnl-2024-324803.
    >> Share

  65. GWAK SY, Kim K, Lee HJ, Cho I, et al
    Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk.
    Heart. 2024 Dec 17:heartjnl-2024-324891. doi: 10.1136/heartjnl-2024-324891.
    >> Share

  66. YONES E, Gunn J, Iqbal J, Morris PD, et al
    Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review.
    Heart. 2024 Dec 12:heartjnl-2024-324802. doi: 10.1136/heartjnl-2024-324802.
    >> Share

  67. DIGREGORIO H, Mansoorshahi S, Carlisle SG, Tovar Pensa C, et al
    Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve.
    Heart. 2024 Dec 10:heartjnl-2024-324669. doi: 10.1136/heartjnl-2024-324669.
    >> Share

    November 2024
  68. SINGH A, Chalmers F, Aslam S, Bolton T, et al
    Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.
    Heart. 2024 Nov 27:heartjnl-2024-324918. doi: 10.1136/heartjnl-2024-324918.
    >> Share

  69. DONAL E, Rouleau L
    Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches.
    Heart. 2024 Nov 7:heartjnl-2024-325097. doi: 10.1136/heartjnl-2024-325097.
    >> Share

  70. BJORN R, Strom JB, Lloyd G, Bhattacharyya S, et al
    Asymptomatic severe degenerative mitral regurgitation.
    Heart. 2024 Nov 7:heartjnl-2024-324739. doi: 10.1136/heartjnl-2024-324739.
    >> Share

    October 2024
  71. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    >> Share

    September 2024
  72. LAI FY, Gibbison B, O'Cathain A, Akowuah E, et al
    Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019).
    Heart. 2024 Sep 3:heartjnl-2024-324292. doi: 10.1136/heartjnl-2024-324292.
    >> Share

    August 2024
  73. GALLI E, Le Ven F, Coisne A, Sportouch C, et al
    Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).
    Heart. 2024 Aug 28:heartjnl-2024-324224. doi: 10.1136/heartjnl-2024-324224.
    >> Share

  74. JAHANGIRI M, Prendergast B
    Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
    Heart. 2024 Aug 7:heartjnl-2024-324054. doi: 10.1136/heartjnl-2024-324054.
    >> Share

    June 2024
  75. RHEE TM, Kim HK
    Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:931-932.
    >> Share

  76. AKITA K, Kageyama S, Suzuki S, Ohno K, et al
    Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:954-962.
    >> Share

  77. KLADOU E, Kochiadakis G, Hamilos M
    Unexpected finding on imaging: an aortic valve mass.
    Heart. 2024;110:939-970.
    >> Share

    April 2024
  78. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
    Sarcopenia and aortic valve disease.
    Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
    >> Share

    March 2024
  79. BIEROWSKI MJ, Warner ED, Edirisuriya CD
    Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
    Heart. 2024;110:507-540.
    >> Share

    February 2024
  80. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    >> Share

  81. TA S, Li J, Hsi DH, Hu R, et al
    Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
    >> Share

    January 2024
  82. WACHTELL K
    Understanding the driving mechanisms of bioprosthetic valve degeneration.
    Heart. 2024;110:223-224.
    >> Share

  83. GUAL-CAPLLONCH F, Pericas P
    Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
    Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
    >> Share

    December 2023
  84. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    >> Share

  85. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
    Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
    >> Share

  86. PAVON AG, Guglielmo M
    Carcinoid heart disease: another step into the knowledge of a rare disease.
    Heart. 2023;110:79-80.
    >> Share

  87. MONDAL S, Kumar SS, Kesavan V
    Case of presyncope with mitral regurgitation.
    Heart. 2023;110:18-74.
    >> Share

  88. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    >> Share

  89. JANDER N, Minners J
    Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
    Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
    >> Share

  90. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    >> Share

    November 2023
  91. HAZEBROEK MR, Verdonschot JAJ
    One step closer to the new frontiers of healthcare for cardiomyopathy patients.
    Heart. 2023;109:1808-1810.
    >> Share

  92. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
    Relationship between the aortic root and the atrioventricular conduction axis.
    Heart. 2023;109:1811-1818.
    >> Share

  93. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
    Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
    Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
    >> Share

  94. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
    Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
    Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
    >> Share

  95. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    >> Share

  96. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    >> Share

  97. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
    Morphology of the mural and commissural atrioventricular junction of the mitral valve.
    Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
    >> Share

  98. TOMASELLI M, Badano LP, Muraru D
    Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
    Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
    >> Share

  99. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
    Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
    Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
    >> Share

    October 2023
  100. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    >> Share

  101. YE Z, Clavel MA, Foley TA, Pibarot P, et al
    Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
    Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
    >> Share

  102. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    >> Share

  103. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
    Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
    Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
    >> Share

  104. OTTO CM, Bartkowiak J, Hahn RT
    Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
    Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
    >> Share

  105. VEERARAGHAVAN S, Kidambi BR
    Sudden-onset breathlessness in a middle-aged man.
    Heart. 2023;109:1601-1650.
    >> Share

  106. DEMAL TJ, Conradi L
    Management of valve dysfunction in patients with mitral annular calcification.
    Heart. 2023;109:1639-1646.
    >> Share

    September 2023
  107. OTTO CM
    Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
    Heart. 2023;109:1419-1421.
    >> Share

  108. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    >> Share

  109. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    >> Share

    August 2023
  110. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
    Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
    Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
    >> Share

  111. BARNES C, Sharma H, Gamble J, Dawkins S, et al
    Management of secondary mitral regurgitation: from drugs to devices.
    Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
    >> Share

  112. JANG MH, Ahn JM, Kang DY, Kim KW, et al
    Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
    >> Share

  113. XU Z, Gong C, Chen Y
    Patient in their 40s with unexplained myocardial hypertrophy.
    Heart. 2023;109:1280-1340.
    >> Share

  114. OTTO CM
    Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
    Heart. 2023;109:1263-1265.
    >> Share

  115. KUSUNOSE K, Ikemiyagi H
    Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
    Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
    >> Share

    July 2023
  116. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
    Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
    Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
    >> Share

  117. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
    Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
    Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
    >> Share

  118. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
    Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
    Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
    >> Share

  119. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    >> Share

  120. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    >> Share

  121. FARRANT J, Dodd S, Vaughan C, Reid A, et al
    Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:1175-1182.
    >> Share

  122. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    >> Share

  123. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
    Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
    Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
    >> Share

    June 2023
  124. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    >> Share

  125. COURTNEY WA, Schultz CJ, Hillis GS
    Aortic valve calcification and outcomes in severe aortic stenosis.
    Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
    >> Share

  126. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
    Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
    Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
    >> Share

  127. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
    Recurrence of syncope after valve replacement in severe aortic stenosis.
    Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
    >> Share

    May 2023
  128. PISLARU SV, Nkomo VT
    Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
    Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
    >> Share

  129. NIENABER CA, Yuan X, Nienaber SA
    Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
    Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
    >> Share

  130. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
    Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
    Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
    >> Share

  131. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
    Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
    Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
    >> Share

  132. HIBINO M, Pandey AK, Hibino H, Verma R, et al
    Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
    Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
    >> Share

  133. OTTO CM
    Heartbeat: Choice of aortic valve intervention in younger adults.
    Heart. 2023;109:807-809.
    >> Share

  134. SHAH BN
    National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
    Heart. 2023;109:817-822.
    >> Share

  135. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
    Matched comparison between external aortic root support and valve-sparing root replacement.
    Heart. 2023;109:832-838.
    >> Share

  136. NUNES MCP, Barbosa JAA, Mocumbi A
    Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
    Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
    >> Share

  137. OH JK, Shen M, Guzzetti E, Tastet L, et al
    Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
    Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
    >> Share

  138. LEEDY D, Elison DM, Farias F, Cheng R, et al
    Transcatheter aortic valve intervention in patients with cancer.
    Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
    >> Share

  139. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
    Pregnancy-related aortic complications in women with bicuspid aortic valve.
    Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
    >> Share

  140. SAN ROMAN JA
    Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
    Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
    >> Share

  141. VAN CAMP G
    Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
    Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
    >> Share

    April 2023
  142. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
    Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
    Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
    >> Share

  143. OTTO CM
    Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:725-727.
    >> Share

  144. RUBIS P
    Low-normal systolic function and hypertrophic cardiomyopathy.
    Heart. 2023;109:732-733.
    >> Share

  145. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    >> Share

  146. CRAMARIUC D, Urheim S
    Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
    Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
    >> Share

  147. RATWATTE S, Playford D, Stewart S, Strange G, et al
    Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
    >> Share

  148. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
    >> Share

    March 2023
  149. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
    Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
    Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
    >> Share

  150. OTTO CM
    Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
    Heart. 2023;109:573-575.
    >> Share

  151. BISWAS A, Shukla A, Kothari SS
    Typical effort angina in a tall adult.
    Heart. 2023;109:605-650.
    >> Share

  152. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
    Inflammatory and thrombotic valvulopathies in autoimmune disease.
    Heart. 2023;109:583-588.
    >> Share

  153. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    >> Share

  154. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
    Perioperative care differences of surgical aortic valve replacement between North America and Europe.
    Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
    >> Share

  155. GEERS J, Bing R
    Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
    Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
    >> Share

  156. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
    Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
    Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
    >> Share

  157. ALI Z, Flynn AW
    Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
    Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
    >> Share

  158. OTTO CM
    Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
    Heart. 2023;109:495-497.
    >> Share

    February 2023
  159. KRIEGER EV, Burke CR, McCabe JM
    Sometimes mechanical, never routine: aortic valve replacement in young adults.
    Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
    >> Share

  160. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
    Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
    Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
    >> Share

  161. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
    Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
    Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016